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Clear cell odontogenic carcinoma of 
the mandible: a treatment strategy
Clear cell odontogenic carcinoma (CCOC) is a rare odontogenic tumor 
of the jaws, histologically characterized by the presence of agglomerates 
of cells with eosinophilic cytoplasm. The patient, a 62-year-old Caucasian 
woman, presented an intraosseous lesion in the mandibular symphysis. A 
clinical examination revealed a discrete volumetric increase with a hard 
consistency, palpable to extraoral and intraoral examinations. Imaging studies 
revealed an extensive radiolucent area, without defined limits, extending 
from the region of the right second premolar to the left canine. Incisional 
biopsy analysis indicated a diagnosis of CCOC. The treatment proposed was 
segmental resection of the mandible with a safety margin. After six months 
without recurrence, definitive mandibular reconstruction was performed using 
an iliac crest graft, followed by rehabilitation with implant-supported denture 
after five months. After three years of post-resection follow-up, the patient 
has shown no evidence of recurrence or metastasis. She continues to be 
under follow-up. To conclude, CCOC must be considered a malignant tumor 
with aggressive behavior. Previous studies have shown that resection with 
free margins is a treatment with a lower rate of recurrence. Nevertheless, 
long-term follow-up is necessary for such patients.
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Introduction
Clear cell odontogenic carcinoma (CCOC) is a 
rare odontogenic tumor of the jaws, histologically 
characterized by the presence of agglomerates of cells 
with eosinophilic cytoplasm. The latest review of the 
English literature revealed about 87 well-documented 
cases of CCOC14.
CCOC has no specific clinical and radiographic 
signs, making its diagnosis difficult. The predominant 
histopathological characteristic is the presence of 
isles of cells with clear or eosinophilic cytoplasm, with 
well-defined outlines and nuclei in a central position8. 
Nevertheless, CCOC is not the only lesion that presents 
clear cells. They may also be observed in neoplasias 
such as calcifying epithelial odontogenic tumor or 
Pindborg tumor, ameloblastoma with a component of 
clear cells, and various odontogenic cysts6,13. Long-
term follow-up is suggested in the literature because 
of its potential for recurrence and distant metastases12.
This study documents a case of extensive CCOC 
of the mandible, treated with segmental resection of 
the mandible, with subsequent reconstruction using 
an autogenous iliac crest bone graft and rehabilitation 
with an implant-supported denture.
Case report
The patient, a 62-year-old Caucasian woman, 
visited our Oral and Maxillofacial Traumatology and 
Surgical service because of the chance discovery of 
an intraosseous lesion in the mandibular symphysis. 
A clinical examination revealed a discrete volumetric 
increase of unknown origin in the anterior region of the 
mandible, with a hard consistency, palpable to extraoral 
and intraoral examinations. The patient did not report 
any pain, absence of continuity solution in the soft 
tissues of the region, had no history of trauma and 
sensory changes in the region, and had non-palpable 
lymph nodes.
Figure 1- Panoramic radiographs – (A) Preoperative radiograph shows an extensive radiolucent area, without defined limits, extending 
from the region of the right second premolar to the left canine. (B) Panoramic radiograph showing the restoration of mandibular morphology 
after 6 months of follow-up; areas suggestive of recurrence are absent. (C) Panoramic radiograph showing the progress of rehabilitation 
with a dental implant after 5 months
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The panoramic radiograph showed an extensive 
radiolucent area, measuring approximately 5 mm 
along its longest axis, without defined limits, and 
extending from the region of the right second premolar 
to the left canine (Figure 1A). Cone beam computed 
tomography revealed an extensive hypoattenuating 
area, with changes in the mandibular outline, as well 
as an area with perforated external cortical bone at 
Figure 2- Clinical features – (A) Transoperative period showing mandibular osteotomy for tumor exeresis. (B) Tumor peace after exeresis. 
(C) Computadorized tomography after one day postoperative showing stability of fixation. (D) Clinical aspect after prosthesis rehabilitation
Figure 3- Histological features – (A, B and C) Lesion with a trabecular pattern, with moderate desmoplasia, without necrosis, showing 
infiltration into the trabecular spaces of the bone tissue (black arrows). (D, E and F) Presence of clear cells (black arrows) confirming 
tumoral trabeculae into mandible bone
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the premolars. Incisional biopsy was performed and 
microscopic diagnosis confirmed a malignant neoplasm 
of the CCOC type.
The treatment proposed was segmental resection 
of the mandible with a safety margin under general 
anesthesia (Figures 2A, 2B and 2C). Histopathological 
analysis of the resected tissue confirmed the diagnosis 
of CCOC, showing evidence of a lesion with a trabecular 
pattern, with moderate desmoplasia, without necrosis, 
showing infiltration into the trabecular spaces of the 
bone tissue (Figures 3A, 3B and 3C; black arrows), 
and the presence of clear cells (Figures 3D, 3E and 3F, 
black arrows). Radiographs of the thorax and abdomen 
were also acquired with the objective of locating areas 
of metastases or an unknown primary tumor, but the 
findings were negative.
After six months of radiographic follow-up, the 
patient showed no signs of recurrence; hence, definitive 
mandibular reconstruction was performed using an 
autogenous iliac crest bone graft (Figure 1B). This was 
followed by rehabilitation with an implant-supported 
denture after five months (Figures 1C and 2D). After 
three years of post-resection follow-up, the patient 
showed no evidence of recurrence or metastasis, 
continuing to be under follow-up by the team.
Discussion
Considered more aggressive than ameloblastoma, 
CCOC occurs more commonly in middle-aged women14. 
This particular case occurred in the anterior region of 
the mandibular bone, which, based on recent literature, 
is considered rare14; CCOC has no established pattern 
of occurrence, since a few years ago the predominant 
area was the anterior mandibular region18.
CCOC has no specific clinical and radiographic signs, 
making it difficult to diagnose. The most frequent 
symptoms include pain or discomfort, broadening 
of the mandible, mobility or displacement of teeth, 
and cortical destruction5,9,13,14,19. In this case, the 
patient showed no painful symptoms, which probably 
contributed to the progression of the lesion and its 
late diagnosis. Radiographic analysis showed that the 
lesion was unilocular, with irregular and poorly defined 
margins and showing evidence of bone destruction. 
Some authors have also mentioned a multilocular 
aspect15,19.
The diagnosis in this case was consistent with 
CCOC. On macroscopic analysis, the fragments had a 
dark-red color, firm-elastic consistency, and hardened 
areas, features of bone tissue. Microscopic analysis 
also revealed moderate desmoplasia with a trabecular 
pattern but without necrosis, infiltrating into the 
trabecular spaces of the bone tissue, as well as nests 
of clear cells (Figure 3).
Clear cells generally result from factors such as 
intracellular accumulation of colorless compounds, 
such as glycogen, lipids, and mucin. Clear cells may 
also be the result of a scarcity of cellular organelles or 
an artifact induced during the fixation or processing of 
tissues10. The presence of clear cells in an odontogenic 
neoplasm may be associated with its supposed origin 
from the dental lamina, which contains clear cells1.
However, clear cells are not exclusive to CCOC. 
They may be observed in numerous neoplasias of 
the maxilla, such as the variant of clear cells seen in 
calcifying epithelial odontogenic tumor, odontogenic 
cysts, clear cell tumors of the salivary glands, and 
variations of carcinoma (e.g., acinar cell carcinoma, 
squamous cell carcinoma, and sebaceous tumors)9.
Some tumors of non-odontogenic origin are also 
characterized by clear cells, histologically similar to 
those seen in CCOC, and occur in organs such as the 
lung, breast, kidney, thyroid gland, and colon18. The 
concern about these lesions is that their metastases 
may be diagnosed in the mandible. Therefore, 
when a patient is diagnosed with CCOC, a thorough 
investigation is recommended to search for metastatic 
lesions of clear cell primary carcinoma, particularly of 
renal origin18. In this case, computed tomography of 
the thorax and abdomen was performed, but lesions 
were not detected.
Because of the rarity of the lesion, the ideal 
treatment approach has not yet been conclusively 
determined. Mandibular resection is indicated 
depending on the time of recurrence as well as its 
aggressiveness and destructiveness18. However, the 
availability of limited data makes it difficult to formulate 
risk factors for tumor recurrence and metastases18. 
Moreover, the degree of nuclear pleomorphism and 
hyperchromatism is extremely variable, and appears 
to be associated with the metastatic potential of the 
tumor4,16. Another important consideration when 
evaluating recurrence is the presence or absence of 
surgical safety margins12.
In some cases of CCOC, in addition to resection, 
bilateral removal of the cervical ganglia has been 
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indicated in mandibular lesions, even in the absence of 
lymphadenopathies on initial clinical examination7,9,20. 
The same observation has been made in the literature 
with regard to the indication for radiotherapy21. 
Unfortunately, the number of patients receiving 
radiotherapy has been insufficient to evaluate the 
benefits of these treatment modalities.
An initial presentation of metastatic lymph nodules 
is rare. Some authors have indicated adjuvant ganglion 
removal therapy8 and/or radiotherapy when there is 
evidence of extensive soft-tissue invasion, perineural 
invasion, or positive lymph nodes, or when removal 
of the tumor with free margins is not feasible2,3,9,12,17.
In this case, partial surgical resection of the 
mandible was performed with margins of healthy 
bone tissue. In the absence of palpable lymph nodes 
and metastatic lesions, ganglion removal was not 
performed. Radiotherapy and chemotherapy were also 
not indicated. The patient has been radiographically 
followed up for three years, without signs of recurrence 
or metastatic lesions. In the literature, the general rate 
of recurrence has been reported as 41.8% and 86.7% 
among patients treated with curettage, and 29.8% 
among those treated with resection21. Among the 
patients with recurrence, 17% had distant metastases. 
The time interval of disease recurrence ranged from 6 
to 24 months for curettage, and 11 to 71 months for 
resection alone9.
Conclusion
In conclusion, CCOC must be considered a malignant 
tumor with an aggressive behavior. Previous studies 
have suggested that resection with free margins is a 
treatment associated with a lower rate of recurrence. 
However, curettage or enucleation appears inadequate. 
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